|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.412 SEK | -2.49% |
|
-4.98% | -68.93% |
| Feb. 23 | Kancera AB Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Feb. 23 | Kancera AB Signs A License Agreement with the University of Newcastle | CI |
Kancera AB (publ) reported earnings results for the full year ended December 31, 2023. For the full year, the company reported revenue was SEK 1.04 million compared to SEK 0.753 million a year ago. Net loss was SEK 64.89 million compared to SEK 52.48 million a year ago.
Basic loss per share from continuing operations was SEK 0.81 compared to SEK 0.9 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -68.93% | 15.61M | |
| -2.31% | 103B | |
| +0.56% | 95.28B | |
| +1.69% | 22.15B | |
| -17.37% | 21.02B | |
| -9.30% | 18.15B | |
| -41.01% | 16.74B | |
| -14.85% | 16.05B | |
| +3.21% | 13.68B | |
| +33.54% | 12.17B |
KANCERA AB 
